NCT00678860 is a clinical trial in Eye Disease, sponsored by National Eye Institute (NEI).

Who is sponsoring NCT00678860?

NCT00678860 is sponsored by National Eye Institute (NEI).

What condition does NCT00678860 study?

NCT00678860 studies Eye Disease.

Is NCT00678860 still recruiting?

NCT00678860 is currently completed. Last updated 2 July 2017.

Last reviewed 2017-07-02 · How we verify

NCT00678860

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validation of Computerized Vision-Targeted Quality-of-Life Questionnaires

Completed Last updated 2 July 2017

What this trial tests

trial in Eye Disease in 147 participants. Completed in 31 October 2011.

Timeline

9 May 2008

31 October 2011

Quick facts

Lead sponsor	National Eye Institute (NEI)
Status	Completed
Study type	OBSERVATIONAL
Enrollment	147
Start date	9 May 2008
Estimated completion	31 October 2011
Sites	1 location across United States

Conditions studied

Eye Disease — all drugs for Eye Disease →

Sponsor

National Eye Institute (NEI)

Who can join

18 and older, any sex, with Eye Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will test and compare computerized and paper versions of eye questionnaires. Questionnaires are used in medicine to gain a better understanding of how a disease can impact a person's quality of life. Computerized versions of such questionnaires are often as good as or better than paper versions, but there has been no direct comparison of the two. This study may help in the development of eye questionnaires used to understand symptoms and monitor patients in clinical trials. People 21 years of age and older with ocular surface disease (OSD) and matched control subjects without OSD may be eligible for this study. All participants undergo the following procedures: * Medical and eye history. * Vision test and examination of the front part of the eye. * Tear measurement: A small piece of paper is placed on the surface of the eye to measure the amount of tears produced. The consistency of the tears is measured by looking at how fast they evaporate from the surface of the eye. * Completion of either paper-based or computer-based version of a questionnaire 15 minutes after the eye examination and completion of the other version within 1 week at home. (Subjects who complete the paper version in the clinic are told how to access the computer version online at home or on a library computer; those who complete the computer version in the clinic are given a paper version to take home.)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Eye Disease

Currently open trials in the same condition.

NCT06771908 — THE ROLE OF HEXAMIDINE DIISETHIONATE (ZAMIDINE®) 1MG/ML 0.6ML EYE DROPS IN THE PROPHYLAXIS OF SURGERY OFTALMIC · recruiting
NCT02821767 — Natural History, Pathogenesis, and Outcome of Ocular Disorders · recruiting

Other National Eye Institute (NEI) trials

Trials by the same sponsor.

NCT06491615 — National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and · recruiting
NCT04289571 — Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease · Phase 1 · recruiting
NCT04833361 — Potential Environmental Causes of Uveal Coloboma · completed
NCT06670989 — Training to Modify Fixational Eye Movements for Optimizing Visual Performance in People With Central Vision Loss · NA · active not recruiting
NCT04591483 — Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00678860 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Eye Institute (NEI)
Last refreshed: 2 July 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00678860.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing